Measuring the Impact of Onco4D® Guidance on Chemotherapy Selection and Outcomes

Starting soon

Conditions studied: Cancer, Chemotherapy Effect

In brief

Millions of cancer patients each year receive chemotherapy causing adverse side effects that lower quality of life without prolonging it. Reliable identification of ineffective therapies can eliminate needless human suffering while increasing overall probability of positive response to treatment. Chemotherapy resistance profiling entails testing whether a patient exhibits strong resistance to a therapy prior to its final selection by the oncologist. The Onco4D® chemotherapy selection assay has recently emerged as means to measure the response of intact tumor biopsies to applied therapeutics by using Doppler detection of infrared light scattered from intracellular motions inside living tissue (known as Motility Contrast Tomography or MCT). Several studies have shown this phenotypic profiling technique to offer high accuracy predicting response and resistance to chemotherapy\[1-5\].

Key facts

Study ID

NCT04891952

Run by

Animated Dynamics, Inc.

People needed

1000

Starts

2021-08-01

Expected to finish

2031-08-01

Last updated by the study team

2021-05-19

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically proven cancer of any type
• Onco4D® test ordered by treating physician
• Ability to understand and willingness to sign an informed consent
• ≥ 18 years old at time of consent

You may not qualify if…

• n/a

Where it is running

• Animated Dynamics, Inc. — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.